The premise behind the network is deceptively simple: nearly every inventor can point to someone who changed their trajectory. It might be a friend who challenged them to think bigger, a teacher who recognized their potential early, a colleague who opened a door at a critical moment, or a leader who invested in their success. Those mentors, the academy argues, help shape careers, drive the discovery of new technologies, and ultimately improve lives. By formalizing that mentorship impulse into a national network, the organization hopes to scale a dynamic that has historically operated informally, one relationship at a time, across laboratories, classrooms, and companies.

The National Invention Ambassadors Network brings together an unusually broad coalition of American innovation leadership. Its inaugural cohort includes accomplished inventors, entrepreneurs, researchers, scientists, engineers, university leaders, industry executives, intellectual property experts, and innovation leaders drawn from across the United States. Collectively, the members represent the full breadth of American innovation, spanning higher education, industry, and government, as well as healthcare and life sciences, national security and defense, advanced manufacturing, aerospace, energy, artificial intelligence, and emerging technologies. The academy emphasizes that the ambassadors together reflect the people, places, disciplines, and sectors driving invention and innovation across the country, a deliberate design choice intended to ensure that the network’s reach extends well beyond any single field or region.

The initiative has drawn explicit endorsement from the federal government. John A. Squires, Under Secretary of Commerce for Intellectual Property and Director of the United States Patent and Trademark Office, said that the network will expand opportunities by inspiring future generations of innovators on the frontiers of today’s discoveries. He added that the USPTO is proud to partner with the National Academy of Inventors to strengthen the nation’s economic competitiveness through the renewal and transformation of American inventiveness into innovations that improve lives and create prosperity. The statement underscores the patent office’s long-standing interest in cultivating a deeper public understanding of intellectual property, which officials view as a foundation for sustained technological and economic leadership.

According to the academy, America’s inaugural National Invention Ambassadors have already built companies, advanced scientific discovery, strengthened public institutions, transformed industries, and launched countless careers. Through the new initiative, they will take on a defined set of responsibilities. They will champion intellectual property education and innovation literacy while mentoring students, researchers, faculty, entrepreneurs, and inventors. They will inspire and help build the next generation of inventors through keynote presentations, workshops, and educational programming. They will work to strengthen technology commercialization practices while fostering collaboration among universities, industry, government, investors, and nonprofit organizations. And they will support regional innovation ecosystems and America’s broader economic competitiveness, connecting local invention communities to national resources and networks.

The emphasis on mentorship as a technical and strategic practice, rather than a vague aspiration, is central to how the network describes itself. Dr. James Conley, a Charter Fellow of the National Academy of Inventors, a National Invention Ambassador, and Clinical Professor of Operations at Northwestern University, said that most inventor journeys are shaped by mentors who share their experience, challenge assumptions, open doors, and create opportunities. He described the network as a meaningful way to help others navigate the path from discovery to impact. That framing reflects a growing recognition in innovation policy that the gap between a laboratory discovery and a market-ready product is rarely closed by technical skill alone; it requires institutional knowledge, legal and financial literacy, and access to experienced guides who have made the journey before.

Technology commercialization, one of the network’s stated focus areas, sits at the heart of that challenge. Universities and federal laboratories produce a steady stream of patented discoveries, yet translating those discoveries into licensed technologies, startups, and products demands coordination among technology transfer offices, investors, industry partners, and regulatory bodies. By deploying ambassadors who have personally navigated patenting, licensing, and company formation, the academy aims to strengthen those practices and reduce the friction that causes promising inventions to stall. The network’s composition, which deliberately includes intellectual property experts alongside inventors and executives, suggests an approach that treats the legal and commercial dimensions of innovation as inseparable from the scientific ones.

The National Academy of Inventors is positioning the network as an open invitation rather than a closed club. The organization is calling on universities, federal agencies, corporations, foundations, entrepreneurs, investors, innovation organizations, and individual innovators to become part of what it describes as a growing national movement. The academy maintains a public roster of ambassadors at its website, where organizations can also request ambassador participation in events and learn more about the NAI-USPTO Joint Project. That accessibility is likely to matter for regional institutions and smaller organizations that lack the internal mentorship infrastructure of large research universities but stand to benefit most from connection to a national pool of experienced inventors.

Dr. Paul R. Sanberg, President of the National Academy of Inventors and Distinguished Professor at the University of South Florida, framed the initiative in terms of legacy. The legacy of any inventor, he said, is more than just the intellectual property and technology they create; it includes the people they inspire, mentor, and prepare to achieve great things. Through the National Invention Ambassadors Network, he argued, everyone has the opportunity to engage America’s leading innovators, invest in the next generation, and ensure an enduring benefit to society. The statement reflects the academy’s broader mission, which centers on recognizing and encouraging inventors with U.S. patents, enhancing the visibility of academic technology and innovation, encouraging the disclosure of intellectual property, and convening partnerships that accelerate the translation of discovery into societal and economic impact.

The network’s launch also signals more to come from the academy’s partnership with the federal patent office. In the coming months, the National Academy of Inventors says it will introduce additional initiatives under its Joint Project Agreement with the USPTO that create new opportunities to connect America’s leading inventors with federal agencies, strategic partners, and mission-driven innovation initiatives. The academy, a member organization comprising U.S. and international universities, governmental agencies, and nonprofit research institutes, counts more than 4,600 individual inventor members and Fellows representing over 300 institutions worldwide. With that scale behind it, the Ambassadors Network represents a test of whether structured, national-scale mentorship can measurably strengthen the pipeline that carries American discoveries from the bench to the marketplace, and whether the country’s most accomplished inventors, given a formal platform, can multiply their impact through the people they prepare to follow them.

Subject of Research: A national inventor mentorship network launched by the National Academy of Inventors in partnership with the USPTO to strengthen innovation education and technology commercialization in the United States.

Article Title: The National Academy of Inventors launches the National Invention Ambassadors Network, expanding work under joint project agreement with USPTO

Article References: The National Academy of Inventors launches the National Invention Ambassadors Network, expanding work under joint project agreement with USPTO. (n.d.). Original publication

Image Credits: AI Generated

DOI: Not provided

Keywords: National Academy of Inventors, USPTO, National Invention Ambassadors Network, innovation, mentorship, intellectual property, technology commercialization, entrepreneurship, inventors, economic competitiveness, STEM education, research universities

The fund operates through a highly competitive process that weighs several explicit criteria, including the availability of intellectual property protection, marketability, commercial potential, technical feasibility and the breadth of a project’s impact. Since its launch in 2011, the program has invested more than 5.1 million dollars and advanced the commercial readiness of 99 innovations born at SUNY campuses. That seed money has catalyzed an additional 41 million dollars in follow-on investment from government agencies, industry licensees and early-stage investors, a leverage ratio that underscores why university systems increasingly treat translational funding as core infrastructure rather than a peripheral perk. Chancellor King framed the program in sweeping terms, describing SUNY as a national leader in interdisciplinary research that develops state-of-the-art technologies, saves lives, transforms industries and serves the public good. The Board of Trustees echoed the sentiment, noting that SUNY research uses revolutionary breakthroughs to fuel economies and empower communities throughout New York State and beyond.

Among the most technically ambitious awards is a project at the University at Albany led by Dr. Spyros Galis, who is building a scalable platform for quantum sensing and imaging that operates at room temperature. Current quantum photonic devices typically require cryogenic cooling to function properly, a constraint that has limited their widespread adoption since refrigeration hardware adds cost, bulk, complexity and substantial energy consumption to any deployment. By re-engineering quantum photonic platforms to work without cooling, the approach promises to reduce all of those barriers simultaneously, opening the door to real-world applications in sensing and imaging that would be impractical if each device needed a cryostat. Quantum sensors exploit delicate quantum states to measure physical quantities with extraordinary precision, and removing the thermal bottleneck is widely regarded as a prerequisite for moving such instruments out of specialized laboratories and into hospitals, factories and field instruments.

Also at Albany, Dr. Gary Saulnier is developing a product called CurrentView, a bedside monitoring system that provides real-time, non-invasive, three-dimensional monitoring of pulmonary perfusion and ventilation. The clinical target is the care of neonatal and pediatric patients with congenital heart disease and other cardiopulmonary conditions, populations in which complete, continuous data can be decisive for treatment quality. The system uses non-invasive electrical measurements to give caregivers a continuous assessment of lung function, drastically improving their ability to make data-informed decisions at the bedside. In intensive care settings for the smallest patients, where repeated imaging or invasive sampling carries real risk, a continuous non-invasive window into how blood and air are moving through the lungs represents a meaningful shift in the information available to clinicians during critical moments.

At Binghamton University, Dr. Nancy Guo has developed ClinSegAI, a secure artificial intelligence platform designed to predict molecular biomarkers directly from standard pathology imaging. Turnaround time for treatment decisions remains a major roadblock to efficient cancer care, because molecular characterization of a tumor often requires additional laboratory workflows that delay therapy. ClinSegAI applies machine learning to detect biomarkers within routine histopathology images, rapidly reducing the time needed to inform treatment decisions and marking what the university describes as a major improvement in the standard of care. Because the model works from images that pathologists already produce, it could in principle slot into existing clinical workflows rather than demanding new tissue collection, and the platform’s emphasis on security addresses the data governance concerns that frequently slow the adoption of medical AI systems.

Binghamton’s second award goes to Dr. John Fetse, who is conducting in vivo validation of engineered lipid nanoparticles for RNA therapeutic delivery. RNA therapeutics offer promising treatment avenues for a wide variety of diseases, but current lipid nanoparticle methods suffer from poor delivery efficiency and raise toxicity concerns that limit proper dosing. Fetse’s innovation incorporates amino acids directly into the lipid molecules themselves, a chemical modification that reduces toxicity risk while improving delivery rates. The approach matters because delivery remains the central bottleneck of the entire RNA medicine field: therapeutic RNA is fragile, quickly degraded, and must be escorted into the right cells in sufficient quantities for a meaningful dose while avoiding harmful accumulation elsewhere. Validating such formulations in living organisms is the essential step toward demonstrating that the chemistry performs outside the controlled conditions of cell culture.

The University at Buffalo is home to two projects that pair semiconductor engineering with human health. Dr. Uttam Singisetti is developing gallium oxide semiconductor transistors for electric vehicle and AI power applications, responding to surging demand from electrified transport and the data center boom for electronics that deliver electricity more efficiently. Gallium oxide is a wide-bandgap material, and transistors built from it can handle high voltages and switch power with less wasted energy than conventional silicon devices, improving performance while lowering costs. The second Buffalo project, led by Dr. Margarita L. Dubocovich, targets advanced phase circadian disorders, in which the body’s internal biological clock is misaligned with a person’s daily schedule or environment. Such misalignment elevates the risk of sleep disruption, cardiovascular disease, depression, cancer and chronic pain. Dubocovich is working toward a first-in-class, orally administered therapeutic that realigns the underlying clock mechanism and restores healthy rhythms, rather than merely masking symptoms with sedatives or stimulants.

At Stony Brook University, Dr. M. Hassan Arbab has developed a handheld, portable terahertz spectral imaging scanner for the diagnosis and triage of skin burns. Burn patients frequently undergo multiple reconstructive surgeries because current clinical techniques assess burn depth with only around 60 to 65 percent accuracy, forcing surgeons to make consequential decisions with incomplete information. Arbab’s device achieves 93 to 95 percent or better accuracy, a dramatic expansion of diagnostic capability that allows clinicians to determine which burns will heal on their own and which require intervention. Terahertz radiation sits between microwave and infrared frequencies and is sensitive to the water content and structural changes in tissue, which makes it well suited to distinguishing viable from non-viable skin without contact or ionizing radiation. Stony Brook President Andrea Goldsmith highlighted the device as an exemplar of the campus’s record of translating research breakthroughs into real-world medical diagnostics.

The final award supports Dr. Yamin Li at SUNY Upstate Medical University, who is developing a lung-targeting drug formulation for sepsis-induced acute respiratory distress syndrome, a life-threatening condition causing lung injury and breathing difficulty that affects roughly three million patients annually. Li’s formulation uses lipid nanoparticles engineered to target the lung, aiming to reduce mortality, shorten intensive care unit stays and decrease ventilator use for patients with the condition. The project addresses a critical unmet need, since treatment options for ARDS remain largely supportive. Campus leaders across the system framed the awards in similar terms: University at Albany President Havidán Rodríguez emphasized transforming promising ideas into real-world impact, Binghamton’s Anne D’Alleva pointed to safer and more effective treatments, Buffalo’s Caroline Attardo Genco cited the strength of the university’s innovation ecosystem in semiconductors and the life sciences, and Upstate’s Dr. Mantosh Dewan described the research mission as improving the human condition. Together, the nine projects illustrate how modest, well-targeted seed funding can push a diverse portfolio of early-stage technologies toward the market readiness that attracts the investors and partners needed to bring them to patients.

Subject of Research: SUNY Technology Accelerator Fund seed grants for commercializing university research technologies

Article Title: SUNY Chancellor King announces funding for groundbreaking technologies to improve lives and protect New Yorkers

Article References: SUNY Chancellor King announces funding for groundbreaking technologies to improve lives and protect New Yorkers. (n.d.). Original publication

Image Credits: AI Generated

DOI: Not provided

Keywords: SUNY, Technology Accelerator Fund, quantum sensing, artificial intelligence, cancer diagnostics, lipid nanoparticles, RNA therapeutics, gallium oxide semiconductors, terahertz imaging, circadian rhythm disorders, ARDS, technology commercialization

The National Commercialization and Translation Institute, or NCTI, is a two-year pilot program specifically tailored to support late-stage federally funded technology companies. Unlike earlier-stage programs that focus on initial concept validation, NCTI targets firms that have already progressed beyond the initial research and development phases. These companies possess validated technologies but often struggle with the final, critical steps required to achieve commercial success. By focusing on this specific segment of the innovation pipeline, the initiative aims to reduce the attrition rate of deep-tech startups that fail to reach the marketplace despite having robust scientific foundations.

The program is led by Ivan Garibay, a UCF Professor of Industrial Engineering and Management Systems and the principal investigator for NCTI. Garibay brings over two decades of expertise in modeling and simulating complex systems that integrate social, technological, and economic factors. His previous role as the Office of Research’s director of technology and innovation at UCF provided him with unique insights into the mechanics of translating laboratory developments into real-world innovations. Garibay emphasizes that NCTI is designed to complement existing federal programs rather than duplicate them, creating a coordinated continuum of support that manages the handoffs from customer discovery to full commercialization.

Support for the initiative extends well beyond the university walls, drawing from a diverse network of more than 30 organizations across industry, academia, and national laboratories. Major industry leaders such as Samsung, Siemens, Lockheed Martin, and L3Harris have submitted letters of support, signaling a strong private-sector interest in accelerating the commercialization of advanced technologies. Academic and research institutions including UC Berkeley, Oak Ridge National Laboratory, Pacific Northwest National Laboratory, and Sandia National Laboratory are also key partners. This broad coalition reflects the national scope of the project and its potential to influence the broader innovation ecosystem by connecting disparate stakeholders in a unified framework.

Michael Georgiopoulos, dean of UCF’s College of Engineering and Computer Science, serves as a co-principal investigator, bringing expertise in electrical and computer engineering, machine learning, and neural networks. Georgiopoulos has previously led NSF-supported efforts focused on strengthening STEM education and student success, which helps fuel the talent pipeline necessary for future innovation. He views NCTI as a unique opportunity to leverage UCF’s prior experience with Technology, Innovation, and Partnership programs to assemble a national network of entrepreneurs, venture capitalists, and subject matter experts. This collaborative approach is intended to help deep-tech companies with proven technologies achieve the market impact their innovations are destined to deliver.

Thomas O’Neal, a professor of industrial engineering and management systems, has been instrumental in building UCF’s commercialization infrastructure since the 1990s. He founded the UCF Business Incubation Program in 1999, which has recently been ranked as the top traditional business incubator in the country by Time magazine. O’Neal also co-leads UCF’s NSF Innovation-Corps program, which launched in 2014 and provides researchers with a structured customer-discovery process. This process helps scientists and engineers evaluate market demand and make informed go or no-go decisions about pursuing commercialization, ensuring that resources are directed toward technologies with genuine market potential.

The initiative also benefits from the expertise of Ron Piccolo, UCF Galloway Professor of Management and co-principal investigator of NCTI. Piccolo leads the Florida Semiconductor Engine, an NSF-funded initiative focused on translating and commercializing promising technologies in the semiconductor domain. His involvement connects NCTI to a broader network of NSF Engines spanning critical technology areas such as energy, quantum computing, and critical materials. Piccolo notes that identifying why some technologies succeed while others fail is central to the institute’s research, with key factors including sufficient capital investment, clarity on customer need, and the discipline to execute business plans effectively.

NCTI will support a select group of NSF-funded small businesses, specifically those in Phase II and Phase IIB of the Small Business Innovation Research and Small Business Technology Transfer programs. These companies operate in deep technology fields such as artificial intelligence, biotechnology, and quantum computing. The support provided includes funding, mentoring, and curated introductions to customers, investors, and industry partners. Each company receives individualized support that begins with diagnostic triage and culminates in a comprehensive commercialization plan. This tailored approach ensures that each firm receives the specific resources and guidance necessary to navigate the unique challenges of their respective technology sectors.

The research component of NCTI will examine how different combinations of support, including capital investment, mentorship, training, and market validation, most effectively accelerate commercialization. By studying the outcomes of these interventions, the institute aims to generate data-driven insights that can inform future federal policy and commercialization strategies. This empirical approach is crucial for understanding the specific mechanisms that drive successful transitions from laboratory to marketplace. The findings will help identify which interventions have the intended impact, allowing for more efficient allocation of resources in the future.

As the initiative launches, it represents a significant step forward in the national effort to enhance the commercialization ecosystem for deep-tech companies. By leveraging UCF’s proven model and a broad network of partners, NCTI aims to reduce the friction that often prevents promising technologies from reaching their full potential. The program’s focus on late-stage companies addresses a critical gap in the innovation pipeline, ensuring that validated technologies are not left to stall in the final stages of development. This coordinated approach to commercialization has the potential to accelerate the delivery of transformative technologies to the market, benefiting both the economy and society at large.

Subject of Research: National Commercialization and Translation Institute (NCTI) initiative led by UCF

Article Title: University of Central Florida-led $20M NSF initiative scales tech-driven business growth at national level

Article References: University of Central Florida-led $20M NSF initiative scales tech-driven business growth at national level. (n.d.). Original publication

Image Credits: AI Generated

DOI: Not provided

Keywords: technology commercialization, National Science Foundation, University of Central Florida, deep tech, innovation ecosystem, small business support, research translation, business incubation, federal funding, market validation, University, Central